Chongqing Hil'An Pharmaceutical

Chongqing Hil'An Pharmaceutical is a comprehensive pharmaceutical enterprise based in Chongqing, China, specializing in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company maintains a strong therapeutic focus on cardiovascular health, gastroenterology, and anti-infective medicines, providing high-quality generic alternatives to essential drugs. Its manufacturing facilities are designed to meet international GMP standards, supporting both the domestic Chinese market and global API exports. Key products in its commercial portfolio include widely prescribed medications such as Amlodipine Besylate, Atorvastatin Calcium, and Clopidogrel Bisulfate. Hil'An is recognized for its integrated approach to drug manufacturing, spanning from chemical synthesis to final packaging, ensuring consistent quality and supply.